CCAP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Crescent Capital BDC Inc (CCAP) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators are bearish, the financial performance shows significant declines, and there are no strong positive catalysts or trading signals to support immediate investment. A hold strategy is recommended until clearer positive trends emerge.
The technical indicators are bearish. The MACD histogram is negative and expanding downward, the RSI is neutral at 38.643, and the moving averages are aligned in a bearish pattern (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 14.009, but there is no strong indication of a reversal.
The company has scheduled its Q4 and fiscal year 2025 earnings release and webcast, which could provide clarity on future performance. Additionally, the company focuses on providing capital solutions to middle-market companies, which aligns with its long-term shareholder value strategy.
The financial performance in Q3 2025 showed significant declines across revenue (-27.29% YoY), net income (-53.48% YoY), and EPS (-53.66% YoY). Gross margin also slightly declined. The technical indicators are bearish, and there are no recent significant insider or hedge fund trading trends. Additionally, there is no recent congress trading data or strong analyst upgrades.
In Q3 2025, Crescent Capital BDC Inc reported a revenue drop of -27.29% YoY to $31.53M, net income dropped -53.48% YoY to $7.10M, and EPS dropped -53.66% YoY to $0.19. Gross margin slightly declined to 86.9%, down -0.31% YoY. These results indicate a challenging financial environment.
No recent analyst rating or price target changes are available for CCAP, leaving a lack of updated Wall Street sentiment on the stock.
